The aim of our study was the evaluation of IL-6 and its soluble receptor complex in critically ill COVID-19 patients with Acute Respiratory Distress Syndrome during the second, 2020 wave of infection to evaluate a possible mechanism of disease progression as correlated to different comorbidity factors. Here, IL6 is linked to COVID-19.